Stock 4170 VECTORITE BIOMEDICAL INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Vectorite Biomedical Inc.

Equities

4170

TW0004170006

Biotechnology & Medical Research

End-of-day quote Taipei Exchange
Other stock markets
 06:00:00 2024-05-28 pm EDT 		5-day change 1st Jan Change
15.25 TWD +1.33% Intraday chart for Vectorite Biomedical Inc. +0.99% -28.57%
Apr. 25 Vectorite Biomedical Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Vectorite Biomedical Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 CI

Business Summary

Vectorite Biomedical Inc is a Taiwan-based company mainly engaged in providing cell product commissioned production services and cell preparations. Products include dendritic cell (DC) vaccines, and natural killer (NK) cell preparations for cancer treatment. The Company also provides immune cell collection, processing and storage services, cell preparation safety testing services, anti-cancer immunity testing services, original design manufacturer (ODM)/ contract development and manufacturing organization (CDMO) services, related medical consulting services, and laboratory quality management services. Products are mainly sold domestically.

Sales per Business

TWD in Million2022Weight2023Weight Delta
Cellular Products
51.0 %
23 54.6 % 29 51.0 % +21.71%
Formulation
36.4 %
12 28.1 % 20 36.4 % +68.81%
Store
8.1 %
5 12.0 % 5 8.1 % -12.54%
Medical Service
2.5 %
1 2.0 % 1 2.5 % +66.78%
Cell Collection Processing
1.9 %
1 3.4 % 1 1.9 % -24.65%

Sales per region

TWD in Million2022Weight2023Weight Delta
Taiwan
100.0 %
43 100.0 % 56 100.0 % +30.15%

Managers

Managers TitleAgeSince
Ming Chang Ou CEO
 Chief Executive Officer - 16-12-31
Hui Ching Yu DFI
 Director of Finance/CFO - 20-03-25

Members of the board

Members of the board TitleAgeSince
Shih Hsing Tsai BRD
 Director/Board Member - 05-02-28
So Chu Chang CHM
 Chairman - 19-06-19
Pai Jung Lai BRD
 Director/Board Member - 19-06-19
Tsung Hsien Yang BRD
 Director/Board Member - 20-06-14
Chang En Tsai BRD
 Director/Board Member - 22-06-14
Hsiang Yueh Meng BRD
 Director/Board Member - 22-06-14
Chien Ming Tang BRD
 Director/Board Member - 22-06-14

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 43,771,000 26,860,374 ( 61.37 %) 0 61.37 %

Company contact information

Vectorite Biomedical, Inc.

6F-11, 97, Section 1 Xintai 5th Road

221 75, New Taipei

+

http://www.vectorite.com.tw
address Vectorite Biomedical Inc.(4170)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sales per Business

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VECTORITE BIOMEDICAL INC. Stock Vectorite Biomedical Inc.
-28.57% 20.61M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+8.38% 114B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+10.13% 104B
BIONTECH SE Stock BioNTech SE
-11.69% 22.5B
ARGENX SE Stock argenx SE
+1.08% 22.57B
GENMAB A/S Stock Genmab A/S
-11.11% 17.95B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-41.90% 16.48B
BEIGENE, LTD. Stock BeiGene, Ltd.
-16.00% 15.82B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+2.28% 13.55B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+20.54% 10.99B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. 4170 Stock
  4. Company Vectorite Biomedical Inc.